To explain the abundance of ASCT2 and LAT1 in cancer cells, a model was proposed in which glutamine enters cells through ASCT2 and is subsequently used as an exchange substrate to import leucine among other essential AAs via LAT1 and to maintain mTORC1 in an activated state (Nicklin et al., 2009). Here, SLC1A5 is linked to cancer.